View Exam | PowerPak

1. Which of the following correctly characterizes a physiologic effect of GLP-1?

A. Stimulation of glucagon secretion from pancreatic α-cells B. Increased rate of gastric emptying C. Increased satiety D. Blocked reabsorption of filtered glucose in the kidney

2. Which of the following is true of the clinical pharmacology of sodium-glucose cotransporter-2 (SGLT-2) inhibitors?

A. Improved glycemic control due to increased glucose disposal via the urine B. Increased risk of genital mycotic infections C. Potential for weight loss D. All of the above

3. When comparing the clinical pharmacology of DPP-4 inhibitors to GLP-1 receptor agonists, which of the following is true?

A. DPP-4 inhibitors are injectable agents, while GLP-1 receptor agonists can be given orally B. DPP-4 inhibitors are considered weight neutral, while GLP-1 receptor agonists therapy can result in weight loss C. DPP-4 inhibitors slow gastric emptying to a larger extent than GLP-1 receptor agonists D. Both therapies carry a high risk of hypoglycemia

4. When used as add-on therapy to metformin in a patient above glycemic goal, SGLT-2 inhibitors would be expected to:

A. Convey a low risk of hypoglycemia B. Induce weight gain C. Have no additional benefit on A1C reduction D. Result in renal toxicity

5. According to the 2017 AACE Algorithm for Adding/Intensifying Insulin, which of the following non-insulin medication classes are recommended for consideration in T2DM patients requiring intensification of prandial control following basal insulin titration?

A. GLP-1 receptor agonists B. SGLT-2 inhibitors C. DPP-4 inhibitors D. All of the above

6. Medications from which of the following medication classes have been shown in clinical trials to convey cardiovascular benefit in patients with T2DM and preexisting cardiovascular disease?

A. GLP-1 receptor agonists B. SGLT-2 inhibitors C. DPP-4 inhibitors D. A and B

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following correctly characterizes a physiologic effect of GLP-1?

2. Which of the following is true of the clinical pharmacology of sodium-glucose cotransporter-2 (SGLT-2) inhibitors?

3. When comparing the clinical pharmacology of DPP-4 inhibitors to GLP-1 receptor agonists, which of the following is true?

4. When used as add-on therapy to metformin in a patient above glycemic goal, SGLT-2 inhibitors would be expected to:

5. According to the 2017 AACE Algorithm for Adding/Intensifying Insulin, which of the following non-insulin medication classes are recommended for consideration in T2DM patients requiring intensification of prandial control following basal insulin titration?

6. Medications from which of the following medication classes have been shown in clinical trials to convey cardiovascular benefit in patients with T2DM and preexisting cardiovascular disease?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following correctly characterizes a physiologic effect of GLP-1?

2. Which of the following is true of the clinical pharmacology of sodium-glucose cotransporter-2 (SGLT-2) inhibitors?

3. When comparing the clinical pharmacology of DPP-4 inhibitors to GLP-1 receptor agonists, which of the following is true?

4. When used as add-on therapy to metformin in a patient above glycemic goal, SGLT-2 inhibitors would be expected to:

5. According to the 2017 AACE Algorithm for Adding/Intensifying Insulin, which of the following non-insulin medication classes are recommended for consideration in T2DM patients requiring intensification of prandial control following basal insulin titration?

6. Medications from which of the following medication classes have been shown in clinical trials to convey cardiovascular benefit in patients with T2DM and preexisting cardiovascular disease?

« Return to Activity

Customers who Purchased
this Activity also Purchased